Please assess the completion status of the following clinical trial:

Trial Title: Losartan in Decompensated Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* hospitalization for decompensated heart failure~* dobutamine dependence~* ejection fraction \< 0.45~* taking angiotensin-converting enzyme inhibitor~Exclusion Criteria:~* serum creatinine \> 3.0 mg/dL~* serum potassium \> 6.0 mEq/L~* systolic blood pressure \< 70 mm Hg~* aortic stenosis~* acute coronary syndrome in the previous 2 months

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Losartan (Type: EXPERIMENTAL): Losartan 50 mg bid orally
- Placebo (Type: PLACEBO_COMPARATOR): Placebo 1 pill bid orally

Based on this trial design, predict the completion outcome and termination type (if applicable).